PetMed Express(PETS) - 2024 Q3 - Earnings Call Transcript

Third quarter sales was $65.3 million, compared to sales of $58.9 million in the same period last year, representing growth of 11% year-over-year. The growth was due to incremental sales from the acquisition of PetCareRx partially offset by declines in PetMeds legacy new order and reorder sales. We continue to experience a single-digit decline in PetMeds legacy reorder sales. Despite having to correct this, I want to reiterate that our focus remains on operating the business and on executing our strategy. O ...